Search
Etoricoxib
go.drugbank.com/drugs/DB01628ApprovedInvestigationalWithdrawnEtoricoxib is a new COX-2 selective inhibitor. … It is approved in more than 60 countries worldwide but not in the US.
Categories: Heterocyclic Compounds, 1-RingProducts: ETORI 1A PHARMA 30MG, ETORI 1A PHARMA 60MGAzathioprine
go.drugbank.com/drugs/DB00993ApprovedInvestigational[L11214] Azathiprine was granted FDA approval on 20 March 1968.[L11214] … Azathioprine is a prodrug of 6-mercaptopurine, first synthesized in 1956 by Gertrude Elion, William Lange, and George Hitchings in an attempt to produce a derivative of 6-mercaptopurine with a better therapeutic
Synonyms: 6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine, 6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurineProducts: Azathioprine Sodium for Injection, AZATHIOPRIN 1A PHARMA 25MGDequalinium
go.drugbank.com/drugs/DB04209Approved[A249255] It is a quaternary ammonium compound,[L42190] as it consists of an amphipathic cation with two aminoquinaldinium rings at both ends of a long hydrophobic hydrocarbon chain.
Products: Fluomizin 10 mg Vaginaltabletten, DONAXYL 10 MG VAJİNAL TABLET, 6 ADETBenperidol
go.drugbank.com/drugs/DB12867ApprovedWithdrawnBenperidol has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders, among others.
Products: BENPERIDOL-NEURAX 10 MG, BENPERIDOL-NEURAX 2 MGPalivizumab
go.drugbank.com/drugs/DB00110ApprovedInvestigationalThe human heavy chain sequence was derived from the constant domains of human IgG1 and the variable framework regions of the VH genes Cor (1) and Cess (2). … Palivizumab is composed of to heavy chains (50.6 kDa each) and two light chains (27.6 kDa each), contains 1-2% carbohydrate by weight and has a molecular weight of 147.7 kDa +/- 1 kDa (MALDI-TOF)
Categories: Antiinfectives for Systemic UseProducts: SYNAGIS STERILE POWDER FOR INJECTION 100 mg/vial, Synagis 100mg/ml solution for InjectionPholcodine
go.drugbank.com/drugs/DB09209ApprovedIllicit[A31738] Pholcodine activity is the suppression of unproductive cough and it also has a mild sedative effect with little or no analgesic effects. … [A31742] Pholcodine is not prescribed in the United States where it is classed as a Schedule I drug. It is categorized as Class B drug in the UK and officially taken out of the shelves in 2008.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds with 4 or More RingsProducts: DHACODINE SYRUP 15 mg/5 ml, DURO-TUSS REGULAR COUGH LIQUID 15 mg/15 mlIsoniazid
go.drugbank.com/drugs/DB00951ApprovedInvestigationalAntibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
Mixtures: PRO TB 4, PRO TB 2Categories: Heterocyclic Compounds, 1-Ring, Antiinfectives for Systemic UseTrospium
go.drugbank.com/drugs/DB00209ApprovedInvestigationalTrospium is an antispasmodic agent used to treat the symptoms of overactive bladder, a condition that causes the bladder muscles to contract uncontrollably.
Categories: Drugs for Urinary Frequency and Incontinence, Drugs for Functional Gastrointestinal DisordersProducts: SPASMOLYT 15 MG, TROSBIO® 15 MGPropiverine
go.drugbank.com/drugs/DB12278ApprovedPropiverine hydrochloride is a bladder detrusor muscle relaxant drug with dual antimuscarinic and calcium-modulating properties for the treatment of OAB [L2317]. … Propiverine is a widely used antimuscarinic drug with a mixed mode of action in the treatment of symptoms associated with overactive bladder (OAB) [A32576].
Categories: Adrenergic alpha-1 Receptor Antagonists, Drugs for Urinary Frequency and IncontinenceProducts: PROPIVERIN 1A PHARMA 5MG, MİCTONORM 15 MG KAPLI TABLET, 56 ADETAmisulpride
go.drugbank.com/drugs/DB06288ApprovedInvestigational[A6752, L32764] Oral tablets of amisulpride is used in European countries as a treatment for acute and chronic schizophrenic disorders, as well as secondary negative symptoms in mental health disorders … a different drug class.
Categories: MATE 1 Inhibitors, MATE 1 SubstratesSynonyms: 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide, 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide